© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Centessa Pharmaceuticals plc (CNTA) shows an Average True Range (ATR) of 1.23 and an Enterprise Value of 890.97M. Its average trading volume over the past 3 months is 1.28M, indicating liquidity. These fundamental metrics provide insight into CNTA's underlying financial health and market activity.
| ATR | 1.23 |
| Enterprise Value | 890.97M |
| Avg Vol (3 Months) | 1.28M |
| Avg Vol (10 Days) | 812.97K |
Centessa Pharmaceuticals plc (CNTA) technical indicators as of March 4, 2026: the SMA 20 is 7.74%, SMA 50 at 9.7%, and SMA 200 at 30.29%. The RSI 14 value is 65.54, suggesting its current momentum. These technical analysis signals help assess CNTA's price trends and potential future movements.
| SMA 20 | 7.74% |
| SMA 50 | 9.7% |
| SMA 200 | 30.29% |
| RSI 14 | 65.54 |
Centessa Pharmaceuticals plc (CNTA) stock performance overview as of March 4, 2026: The 52-week high is $30.58 (currently -12.46% below), and the 52-week low is $9.6 (currently 178.85% above). Over the past year, CNTA's performance is 54.14%, compared to the S&P 500's 14.31% change.
| 52-Week High | 30.58 |
| 52-Week High Chg | -12.46% |
| 52-Week Low | 9.6 |
| 52-Week Low Chg | +178.85% |
| S&P 500 52-Week Chg | 14.31% |
According to market data, Centessa Pharmaceuticals plc (CNTA) stock's recent performance metrics show that over the last month, CNTA is -8.25%, with a Year-to-Date (YTD) performance of -8.36%. Over the past year, the stock has seen a 54.14% change. These figures summarize CNTA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 27.56 | 27.56 | 30.58 | 30.58 | 30.58 | 27.56 |
| Low | 25.38 | 22.5 | 21.5 | 15.01 | 9.6 | 21.5 |
| Performance | +4.09% | -8.25% | -0.43% | +42.71% | +54.14% | -8.36% |
According to current financial data, CNTA stock's P/E (TTM) ratio is -14.69, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for CNTA, including P/S (238.06), P/B (11.82), and P/FCF (-19.71), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | CNTA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -14.69 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 238.06 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 11.82 | 4.44 | 7.03 | 4.87 |
| P/FCF (TTM) | -19.71 | -327.99 | -228.24 | 33.92 |